FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Yves Pierga

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Circulating Neoplastic Cells

Co-author Network

Publications

TOP 3
François-Clément Bidard; Tanja Fehm; Daniel F Hayes; Michail Ignatiadis; Wolfgang Janni; Carlo Messina; Volkmar Müller; Costanza Paoletti; Martine Piccart; Catherine Alix-Panabières; Jeffrey B Smerage; Jean-Yves Pierga
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
Antonio Giordano; David Hajage; Gabriel N Hortobagyi; Jean-Yves Pierga; James M Reuben; Joseph Bland; Massimo Cristofanilli; Brian L Egleston; Francois-Clement Bidard
Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.
François-Clément Bidard; Jean-Yves Pierga; Jean-Charles Soria; Jean Paul Thiery
Translating metastasis-related biomarkers to the clinic--progress and pitfalls.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Yves Pierga (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: François-Clément Bidard; Tanja Fehm; Daniel F Hayes; Michail Ignatiadis; Wolfgang Janni; Carlo Messina; Volkmar Müller; Costanza Paoletti; Martine Piccart; Catherine Alix-Panabières; Jeffrey B Smerage; Jean-Yves Pierga
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
Cancer metastasis reviews 2013;32(1-2):179-88.
2013: Antonio Giordano; David Hajage; Gabriel N Hortobagyi; Jean-Yves Pierga; James M Reuben; Joseph Bland; Massimo Cristofanilli; Brian L Egleston; Francois-Clement Bidard
Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(6):1596-602.
2013: François-Clément Bidard; Jean-Yves Pierga; Jean-Charles Soria; Jean Paul Thiery
Translating metastasis-related biomarkers to the clinic--progress and pitfalls.
Nature reviews. Clinical oncology 2013;10(3):169-79.
2013: C Vaysse; Anne Vincent-Salomon; A L Rivain; Roman Rouzier; Xavier Sastre-Garau; Brigitte Sigal-Zafrani; J Sroussi; Séverine Alran; Catherine Belichard; Benoit Couturaud; J G Feron; Alfred Fitoussi; Virginie Fourchotte; Youlia KIROVA; Fatima Laki; S Lasry; P Mallon; C Ngo; Jean-Yves Pierga; F Reyal
Prediction of axillary lymph node status in male breast carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(2):370-6.
2013: Fabien Reyal; Alexia Savignoni; Brigitte Sigal-Zafrani; Anne Vincent-Salomon; Séverine Alran; Bernard Asselain; Marc A Bollet; Paul-Henri Cottu; Véronique Dieras; Jean-Guillaume Feron; Virginie Fourchotte; Alain Fourquet; David Hajage; Youlia KIROVA; Fatima Laki; Jean-Yves Pierga; Xavier Sastre-Garau
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.
PloS one 2013;8(3):e55901.
2013: Thomas Bachelot; Jacques Bonneterre; Marine Gilabert; Pierre Heudel; Intidar Labidi-Gally; Emilie Le Rhun; Jean-Yves Pierga; Anthony Gonçalves
[Systemic treatment of brain metastases from breast cancer: cytotoxic chemotherapy and targeted therapies].
Bulletin du cancer 2013;100(1):7-14.
2013: Thomas Bachelot; Mario Campone; Claire Cropet; Hervé Curé; Florence Dalenc; Véronique Diéras; Julien Domont; Jean-Marc Ferrero; Anthony Gonçalves; Maya Gutierrez; Marta Jimenez; Emilie Le Rhun; Marianne Leheurteur; Jean-Yves Pierga; Gilles Romieu; Catherine Labbe-Devilliers
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study.
The lancet oncology 2013;14(1):64-71.
2013: Véronique Diéras; Véronique Girre; Valérie Laurence; Alain Livartowski; A Lortholary; Sylvie Assadourian; R Delva; D Semiond; Jean-Yves Pierga
Cabazitaxel in patients with advanced solid tumours: results of a Phase I and pharmacokinetic study.
European journal of cancer (Oxford, England : 1990) 2013;49(1):25-34.
2012: J Jacob; Youlia KIROVA; Jean-Yves Pierga; Virginie Fourchotte; Marc A Bollet
[A case of cutaneous mammary re-irradiation].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2012;16(7):638-40.
2012: Julien Autebert; François-Clément Bidard; Benoit Coudert; Stéphanie Descroix; Laurent Malaquin; Jean-Yves Pierga; Jean-Louis Viovy
Microfluidic: an innovative tool for efficient cell sorting.
Methods (San Diego, Calif.) 2012;57(3):297-307.
2012: Anne-Claire Hardy-Bessard; Leila Kockler; Alain Lortholary; Alain Monnier; Maria Pavlyuk; Marie-Aude Coulon Sfairi; Florence Dalenc; Rémy Delva; Marc Espié; Xavier Pivot; Daniel Serin; Corinne Veyret; Jean-Yves Pierga
[Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France].
Bulletin du cancer 2012;99(6):609-18.
2012: Christophe Le Tourneau; Jean-Yves Pierga; Brigitte Sigal-Zafrani; Séverine Alran; Philippe Beuzeboc; Sarah Dettwiler; Véronique Diéras; Paul Fréneaux; Valérie Laurence; Anne Vincent-Salomon
Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancer.
American journal of clinical oncology 2012;35(3):242-6.
2012: Hélène Vegas; Thierry André; Francois-Clement Bidard; François-Régis Ferrand; Florence Huguet; Pascale Mariani; Jean-Yves Pierga
[Disseminated and circulating tumor cells in gastrointestinal oncology].
Bulletin du cancer 2012;99(5):535-44.
2012: Francois-Clement Bidard; V Boige; A de Gramont; M Ducreux; F R Ferrand; P Hammel; F Huguet; Christophe Louvet; D Malka; P Mariani; T Andre; Jean-Yves Pierga
Disseminated and circulating tumor cells in gastrointestinal oncology.
Critical reviews in oncology/hematology 2012;82(2):103-15.
2012: Jean-Yves Pierga; Henri Roché; Thomas Bachelot; François-Clément Bidard; Mario Campone; Emmanuelle Charafe-Jauffret; Thierry Delozier; Jean-Marc Ferrero; Joseph GLIGOROV; Sandrine Kraemer; Florence Lerebours; Maria Pavlyuk; Thierry Petit; Patrice Viens
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study.
The lancet oncology 2012;13(4):375-84.
2012: S Haberer; Youlia KIROVA; Romuald Le Scodan; P Moisson; Jean-Yves Pierga; Fabien Reyal; Alexia Savignoni; D Stevens; L Belin; François Campana; Didier Decaudin; Alain Fourquet; Marc A Bollet
[Breast conserving surgery in locoregional treatment of breast carcinoma after Hodgkin lymphoma].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2012;16(2):128-35.
2012: D Malka; Jean-Yves Pierga; N Vimond; E François; Marie-Pierre Galais; P Guichard; N Jacques; Antoine Adenis; V Boige; Eveline Boucher; B Chauffert; Thierry Conroy; F Cvitkovic; Michel Ducreux; Françoise Farace
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(4):919-27.
2012: Javier Cortés; Hernan Cortes-Funes; Suzette Delaloge; David T Bollag; Mireia Caralt; Jean-Yves Pierga; Kathleen I Pritchard; David W Miles
Safety of bevacizumab in metastatic breast cancer patients undergoing surgery.
European journal of cancer (Oxford, England : 1990) 2012;48(4):475-81.
2012: Jean-Yves Pierga; E Rolland; T Bachelot; E Brain; M Campone; Suzette Delaloge; Véronique Diéras; D Hajage; Claire Mathiot; L Mignot; Francois-Clement Bidard
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):618-24.
2012: Sophie Haberer; Youlia KIROVA; Romuald Le Scodan; Patricia Moisson; Jean-Yves Pierga; Fabien Reyal; Alexia Savignoni; Denise Stevens; Lisa Belin; François Campana; Didier Decaudin; Alain Fourquet; Marc A Bollet
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
International journal of radiation oncology, biology, physics 2012;82(2):e145-52.
2012: Fabien Reyal; Roman Rouzier; Xavier Sastre-Garau; Claire Senechal; Brigitte Sigal-Zafrani; Anne Vincent-Salomon; Catherine Belichard; Francois-Clement Bidard; Paul-Henri Cottu; Emmanuel de Gournay; Yann De Rycke; Jean-Guillaume Feron; Virginie Fourchotte; Jean-Marc Guinebretiere; Youlia KIROVA; Florence Lerebours; Jean-Yves Pierga; Charles Coutant
Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.
PloS one 2012;7(10):e47390.
2012: Maura Campitelli; Paul-Henri Cottu; Jérôme Couturier; Anne de La Rochefordière; Virginie Fourchotte; Emmanuelle Jeannot; Olivier Lantz; Emmanuelle Lappartient; Martine Peter; Peter Petrow; Jean-Yves Pierga; Stéphanie Saada; Séverine Alran; Xavier Sastre-Garau
Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients.
PloS one 2012;7(8):e43393.
2012: Fabien Reyal; Brigitte Sigal-Zafrani; Anne Vincent-Salomon; Marc A Bollet; Martial Caly; Sabrina Carpentier; Paul Cottu; Véronique Dieras; David Gentien; Hélène Peyro-Saint-Paul; Jean-Yves Pierga; Xavier Sastre-Garau
Respective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinoma.
PloS one 2012;7(4):e35184.
2012: Christoph Thomssen; Laura Biganzoli; Hernan Cortes-Funes; Anja Duenne; Bella Kaufman; Katarína Petráková; Jean-Yves Pierga; Kathleen I Pritchard; Ian Smith
First-line bevacizumab-containing therapy for triple-negative breast cancer: analysis of 585 patients treated in the ATHENA study.
Oncology 2012;82(4):218-27.
2012: Francois-Clement Bidard; Etienne Brain; Mario Campone; Paul-Henri Cottu; Suzette Delaloge; David Hajage; Claire Mathiot; Thomas Bachelot; Philippe Beuzeboc; Emilie Rolland; Jean-Yves Pierga
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study.
Breast cancer research : BCR 2012;14(1):R29.
2011: Emiel Rutgers; Alastair M Thompson; Laura Van 't Veer; Giuseppe Viale; Anita Vindevoghel; Gustavo Werutsky; Suzette Delaloge; Ulrike Nitz; Rodolfo Passalacqua; Martine J Piccart-Gebhart; Jean-Yves Pierga; Peter M Ravdin; Isabel Teresa Rubio; Jan Bogaerts; Fatima Cardoso
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase.
European journal of cancer (Oxford, England : 1990) 2011;47(18):2742-9.
2011: Ian Smith; Christoph Thomssen; Silvana Saracchini; Laura Biganzoli; Hernan Cortes-Funes; Anja-Alexandra Duenne; Bella Nisenbaum; Ignacio Pelaez; Jean-Yves Pierga; Kathleen I Pritchard
Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial.
Breast cancer research and treatment 2011;130(1):133-43.
2011: Ciprian Chira; Najib Derhem; Alain Fourquet; Julian Jacob; Marc A Bollet; François Campana; Virginie Marchand; Jean-Yves Pierga; Youlia M Kirova
Preliminary experience of whole-brain radiation therapy (WBRT) in breast cancer patients with brain metastases previously treated with bevacizumab-based chemotherapy.
Journal of neuro-oncology 2011;105(2):401-8.
2011: Cyrus Chargari; Paul-Henri Cottu; Véronique Diéras; Alain Fourquet; Hind Riahi Idrissi; Marc A Bollet; François Campana; Jean-Yves Pierga; Youlia M Kirova
Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients.
International journal of radiation oncology, biology, physics 2011;81(3):631-6.
2011: Maher M Almubarak; Bernard Baranger; Simon P Bennett; Wulfran Cacheux; Patricia de Cremoux; Marie-Christine Falcou; Marick Laé; Jean-Yves Pierga; Fabien Reyal; Remy J Salmon; Pascale Mariani
Gastric metastasis of breast cancer: a single centre retrospective study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(10):823-7.
2011: Marie-Christine Etienne-Grimaldi; Patricia Formento; Armelle Degeorges; Jean-Yves Pierga; Rémi Delva; Xavier Pivot; Florence Dalenc; Marc Espié; Corinne Veyret; Jean-Louis Formento; Mireille Francoual; Magali Piutti; Patricia de Crémoux; Gérard Milano
Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.
British journal of clinical pharmacology 2011;71(6):921-8.
2011: Hélène Petithuguenin Gauthier; Jean-Yves Pierga; Francois-Clement Bidard; Paul-Henri Cottu; Véronique Girre; Marie-Noëlle Guilhaume; Valérie Laurence; Alain Livartowski; L Mignot; Véronique Dieras
[Survival of breast cancers patients with meningeal carcinoma].
Bulletin du cancer 2011;98(4):391-8.
2011: Véronique Diéras; Jean-Yves Pierga
[Brain metastasis of breast tumors and blood brain barrier].
Bulletin du cancer 2011;98(4):385-9.
2011: C Daveau; Alexia Savignoni; S Abrous-Anane; Jean-Yves Pierga; Fabien Reyal; C Gautier; Youlia KIROVA; Rémi Dendale; François Campana; Alain Fourquet; Marc A Bollet
[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2011;15(2):106-14.
2011: Caroline Daveau; Alexia Savignoni; Soumya Abrous-Anane; Jean-Yves Pierga; Fabien Reyal; Chantal Gautier; Youlia KIROVA; Rémi Dendale; François Campana; Alain Fourquet; Marc A Bollet
Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?
International journal of radiation oncology, biology, physics 2011;79(5):1452-9.
2011: Soumya Abrous-Anane; Alexia Savignoni; Caroline Daveau; Jean-Yves Pierga; Chantal Gautier; Fabien Reyal; Rémi Dendale; François Campana; Youlia KIROVA; Alain Fourquet; Marc A Bollet
Management of inflammatory breast cancer after neoadjuvant chemotherapy.
International journal of radiation oncology, biology, physics 2011;79(4):1055-63.
2011: Jaco Kraan; Stefan Sleijfer; Michiel Strijbos; Michail Ignatiadis; Dieter Peeters; Jean-Yves Pierga; Francoise Farace; Sabine Riethdorf; Tanja Fehm; Laura Zorzino; Arjan G J Tibbe; Marisa Maestro; Rafael Gisbert-Criado; Graeme Denton; Johann S de Bono; Caroline Dive; John A Foekens; Jan W Gratama
External quality assurance of circulating tumor cell enumeration using the CellSearch(®) system: a feasibility study.
Cytometry. Part B, Clinical cytometry 2011;80(2):112-8.
2011: Eugenie Guillot; Benoit Couturaud; Fabien Reyal; Alain Curnier; Julie Ravinet; Marick Laé; Marc Bollet; Jean-Yves Pierga; Remy Salmon; Alfred Fitoussi
Management of phyllodes breast tumors.
The breast journal 2011;17(2):129-37.
2011: Julie Gonin; Frédérique Larousserie; Bertrand Dousset; Julien Rousseau; Olivier Delattre; Charlotte Waintrop; Vassili Tsatsaris; Jean-Yves Pierga; Marie-Cécile Vacher-Lavenu; Frédérique Tissier
[An unusual adrenal tumor: Ewing tumor].
Annales de pathologie 2011;31(1):28-31.
2011: David Hajage; Hugo M Horlings; Jean-Yves Pierga; Bernard Asselain; Marc A Bollet; Martial Caly; Yann De Rycke; Xavier Sastre; Alexia Savignoni; Claire Senechal; Brigitte Sigal-Zafrani; Marc J Van de Vijver; Anne Vincent-Salomon; Fabien Reyal
External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.
PloS one 2011;6(11):e27446.
2011: Fabien Reyal; Roman Rouzier; Remy J Salmon; Xavier Sastre-Garau; Brigitte Sigal-Zafrani; Serge Uzan; Anne Vincent-Salomon; Severine Alran; Martine Antoine; Marc A Bollet; Berenice Depont-Hazelzet; Virginie Fourchotte; Jean-Yves Pierga; Yann De Rycke
The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.
PloS one 2011;6(5):e20297.
2011: Lucas Caussa; Youlia KIROVA; Nathalie Gault; Jean-Yves Pierga; Alexia Savignoni; François Campana; Rémi Dendale; Alain Fourquet; Marc A Bollet
The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: a single-institution study.
European journal of cancer (Oxford, England : 1990) 2011;47(1):65-73.
2010: Eléonore Gravier; Gaëlle Pierron; Anne Vincent-Salomon; Nadège Gruel; Virginie Raynal; Alexia Savignoni; Yann De Rycke; Jean-Yves Pierga; Carlo LUCCHESI; Fabien Reyal; Alain Fourquet; Sergio Roman-Roman; François Radvanyi; Xavier Sastre-Garau; Bernard Asselain; Olivier Delattre
A prognostic DNA signature for T1T2 node-negative breast cancer patients.
Genes, chromosomes & cancer 2010;49(12):1125-34.
2010: Cyrus Chargari; François Campana; Jean-Yves Pierga; Lionel Védrine; Damien Ricard; Sylvestre Le Moulec; Alain Fourquet; Youlia M Kirova
Whole-brain radiation therapy in breast cancer patients with brain metastases.
Nature reviews. Clinical oncology 2010;7(11):632-40.
2010: H Gauthier; M N Guilhaume; Francois-Clement Bidard; Jean-Yves Pierga; Véronique Girre; Paul-Henri Cottu; Valérie Laurence; Alain Livartowski; L Mignot; Véronique Diéras
Survival of breast cancer patients with meningeal carcinomatosis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(11):2183-7.
2010: Pascale Mariani; Marick Lae; Armelle Degeorges; Wulfran Cacheux; Emmanuelle Lappartient; Audrey Margogne; Jean-Yves Pierga; Véronique Girre; Laurent Mignot; Marie-Christine Falcou; Rémy-Jacques Salmon; Olivier Delattre; Patricia de Cremoux
Concordant analysis of KRAS status in primary colon carcinoma and matched metastasis.
Anticancer research 2010;30(10):4229-35.
2010: Antoine-Emmanuel Saliba; Laure Saias; Eleni Psychari; Nicolas Minc; Damien Simon; François-Clément Bidard; Claire Mathiot; Jean-Yves Pierga; Vincent Fraisier; Jean Salamero; Véronique Saada; Françoise Farace; Philippe Vielh; Laurent Malaquin; Jean-Louis Viovy
Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(33):14524-9.
2010: Jean-Yves Pierga; Suzette Delaloge; Marc Espié; Etienne Brain; Brigitte Sigal-Zafrani; Marie-Christine Mathieu; Philippe Bertheau; Jean-Marc Guinebretière; Marc Spielmann; Alexia Savignoni; Michel Marty
A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.
Breast cancer research and treatment 2010;122(2):429-37.
2010: Francois-Clement Bidard; Claire Mathiot; Suzette Delaloge; E Brain; S Giachetti; Patricia de Cremoux; Michel Marty; Jean-Yves Pierga
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(4):729-33.
2009: Peter Barrett-Lee; Francois-Clement Bidard; Jean-Yves Pierga
Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
Cancer treatment reviews 2009;35(7):582-9.
2009: Francois-Clement Bidard; Youlia KIROVA; Anne Vincent-Salomon; Séverine Alran; Yann De Rycke; Brigitte Sigal-Zafrani; Xavier Sastre-Garau; L Mignot; Alain Fourquet; Jean-Yves Pierga
Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(11):1836-41.
2009: Youlia KIROVA; L Caussa; B Granger; Alexia Savignoni; Rémi Dendale; François Campana; H Tournat; Jean-Yves Pierga; Alain Fourquet; M-A Bollet
[Monocentric evaluation of the skin and cardiac toxicities of the concomitant administration of trastuzumab and radiotherapy].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2009;13(4):276-80.
2009: Anne Vincent-Salomon; Martial Caly; Yann De Rycke; Paul Fréneaux; Jerzy Klijanienko; Marick Laé; Frédérique Viard; Claude Nos; Francois-Clement Bidard; Séverine Alran; Rémy Salmon; Youlia KIROVA; Jean-Yves Pierga; Brigitte Sigal-Zafrani; Xavier Sastre-Garau
Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.
European journal of cancer (Oxford, England : 1990) 2009;45(11):1979-86.
2009: Cyrus Chargari; Youlia KIROVA; Véronique Diéras; Pablo CASTRO-PENA; Pablo Castro Pena; Francois Campana; Paul-Henri Cottu; Jean-Yves Pierga; Alain Fourquet
Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients.
Journal of neuro-oncology 2009;93(3):379-84.
2009: Francois-Clement Bidard; M N Guilhaume; H Gauthier; Paul-Henri Cottu; Véronique Diéras; Jean-Yves Pierga
Meningeal carcinomatosis in HER2-overexpressing breast cancers.
Journal of neuro-oncology 2009;93(2):287-8.
2008: Jean-Yves Pierga; Francois-Clement Bidard; Claire Mathiot; Etienne Brain; Suzette Delaloge; Sylvie Giachetti; Patricia de Cremoux; Rémy Salmon; Anne Vincent-Salomon; Michel Marty
Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(21):7004-10.
2008: Véronique Girre; Marie-Christine Falcou; Mathilde Gisselbrecht; Geneviève Gridel; Véronique Mosseri; Carole Bouleuc; Rollon Poinsot; Lionel Vedrine; Liliane Ollivier; Valérie Garabige; Jean-Yves Pierga; Véronique Diéras; Laurent Mignot
Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?
The journals of gerontology. Series A, Biological sciences and medical sciences 2008;63(7):724-30.
2008: Francois-Clement Bidard; Anne Vincent-Salomon; Stéphanie Gomme; Claude Nos; Yann De Rycke; Jean Paul Thiery; Brigitte Sigal-Zafrani; Laurent Mignot; Xavier Sastre-Garau; Jean-Yves Pierga
Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3306-11.
2008: Anne Vincent-Salomon; Francois-Clement Bidard; Jean-Yves Pierga
Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues.
Journal of clinical pathology 2008;61(5):570-6.
2008: Youlia KIROVA; Yann De Rycke; Laetitia Gambotti; Jean-Yves Pierga; Bernard Asselain; Alain Fourquet
Second malignancies after breast cancer: the impact of different treatment modalities.
British journal of cancer 2008;98(5):870-4.
2008: Paul-Henri Cottu; J Asselah; M Lae; Jean-Yves Pierga; Véronique Diéras; L Mignot; Brigitte Sigal-Zafrani; Anne Vincent-Salomon
Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):595-7.
2008: Francois-Clement Bidard; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Véronique Diéras; Claire Mathiot; L Mignot; JEAN PAUL THIERY; Xavier Sastre-Garau; Jean-Yves Pierga
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):496-500.
2008: Francois-Clement Bidard; Jean-Yves Pierga; Anne Vincent-Salomon; Marie-France Poupon
A "class action" against the microenvironment: do cancer cells cooperate in metastasis?
Cancer metastasis reviews 2008;27(1):5-10.
2008: Marc A Bollet; Alexia Savignoni; Jean-Yves Pierga; M Lae; Virginie Fourchotte; Youlia KIROVA; Rémi Dendale; François Campana; Brigitte Sigal-Zafrani; Rémy Salmon; Alain Fourquet; Anne Vincent-Salomon
High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies.
British journal of cancer 2008;98(4):734-41.
2008: Francois-Clement Bidard; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Manuel Rodrigues; Véronique Diéras; Laurent Mignot; Xavier Sastre-Garau; Marie-France Poupon; Jean-Yves Pierga
Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
Clinical & experimental metastasis 2008;25(8):871-5.
2007: Marc A Bollet; Youlia KIROVA; Guillemette Antoni; Jean-Yves Pierga; Brigitte Sigal-Zafrani; Fatima Laki; François Campana; Rémi Dendale; Rémy Salmon; Paul-Henri Cottu; Alain Fourquet
Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;85(3):336-45.
2007: Brigitte Sigal-Zafrani; Marc A Bollet; G Antoni; Alexia Savignoni; Anne Vincent-Salomon; Jean-Yves Pierga; Rémy Salmon; Xavier Sastre-Garau; Alain Fourquet
Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?
British journal of cancer 2007;97(8):1046-52.
2007: Anne Vincent-Salomon; Jean-Yves Pierga; Jérôme Couturier; C D d'Enghien; Claude Nos; Brigitte Sigal-Zafrani; M Lae; Paul Fréneaux; Véronique Diéras; Jean-Paul Thiéry; Xavier Sastre-Garau
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
British journal of cancer 2007;96(4):654-9.
2007: Anne Vincent-Salomon; Nadège Gruel; Carlo LUCCHESI; gaetan macgrogan; Rémi Dendale; Brigitte Sigal-Zafrani; Michel Longy; Virginie Raynal; Gaëlle Pierron; Isabelle de Mascarel; Corinne Taris; Dominique Stoppa-Lyonnet; Jean-Yves Pierga; Rémy Salmon; Xavier Sastre-Garau; Alain Fourquet; Olivier Delattre; Patricia de Cremoux; Alain Aurias
Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
Breast cancer research : BCR 2007;9(2):R24.
2006: Jean Paul Thiery; Xavier Sastre-Garau; B Vincent-Salomon; X Sigal-Zafrani; Jean-Yves Pierga; C Decraene; J P Meyniel; E Gravier; Bernard Asselain; Yann De Rycke; P Hupe; Emmanuel Barillot; S Ajaz; Marisa M Faraldo; Marie-Ange Deugnier; Marina A Glukhova; D Medina
Challenges in the stratification of breast tumors for tailored therapies.
Bulletin du cancer 2006;93(8):E81-9.
2005: Jean-Yves Pierga; Jorge S Reis-Filho
Ewing's sarcoma of the rectum: can we afford not to use molecular pathology?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7761-2; author reply 7762.
2005: Véronique Diéras; Jacques Bonneterre; Valérie Laurence; Marian Degardin; Jean-Yves Pierga; Marie-Edith Bonneterre; Sandrine Marreaud; Denis Lacombe; Pierre Fumoleau
Phase I combining a P-glycoprotein inhibitor, MS209, in combination with docetaxel in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6256-60.
2005: Stephan Braun; Florian D Vogl; Bjørn Naume; Wolfgang Janni; Michael P Osborne; R Charles Coombes; Günter Schlimok; Ingo J Diel; Bernd Gerber; Gerhard Gebauer; Jean-Yves Pierga; Christian Marth; Daniel Oruzio; Gro Wiedswang; Erich Solomayer; Günther Kundt; Barbara Strobl; Tanja Fehm; George Y C Wong; Judith Bliss; Anne Vincent-Salomon; Klaus Pantel
A pooled analysis of bone marrow micrometastasis in breast cancer.
The New England journal of medicine 2005;353(8):793-802.
2005: Catherine Delbaldo; Jean-Yves Pierga; Véronique Dieras; Sandrine Faivre; Valérie Laurence; Jean-Claude Vedovato; Marc Bonnay; Matthias Mueser; Arno Nolting; Andreas Kovar; Eric Raymond
Pharmacokinetic profile of cetuximab (Erbitux) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 2005;41(12):1739-45.
2005: Valérie Laurence; Jean-Yves Pierga; Sophie Barthier; Antoine Babinet; Claire Alapetite; Thao Palangié; Gonzague De Pinieux; Philippe Anract; Pierre Pouillart
Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor.
American journal of clinical oncology 2005;28(3):301-9.
2005: Jean-Yves Pierga; Charlyne Bonneton; Henri Magdelénat; Anne Vincent-Salomon; Claude Nos; Evelyne Boudou; Pierre Pouillart; Jean Paul Thiery; Patricia de Cremoux
Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.
International journal of cancer. Journal international du cancer 2005;114(2):291-8.
2005: Jean-Pierre Delord; Jean-Yves Pierga; Véronique Dieras; Frédérique Bertheault-Cvitkovic; Francois Turpin; François Lokiec; Isabelle Lochon; Etienne Chatelut; Pierre Canal; Rosine Guimbaud; D Mery-Mignard; X Cornen; Z Mouri; Roland Bugat
A phase I clinical and pharmacokinetic study of capecitabine (Xeloda) and irinotecan combination therapy (XELIRI) in patients with metastatic gastrointestinal tumours.
British journal of cancer 2005;92(5):820-6.
2004: Patricia de Cremoux; Véronique Diéras; Marie-France Poupon; Henri Magdelénat; Brigitte Sigal-Zafrani; Alain Fourquet; Jean-Yves Pierga
[Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
Bulletin du cancer 2004;91(12):917-27.
2004: Jean-Yves Pierga; Pierre Fumoleau; Y Brewer; Laurent Zelek; D Martin; Francois Turpin; Marie-Josèphe Goudier; M Gil-Delgado; J L Baticle; Moïse Namer; Philippe Chollet; W Sutherland; Jean-Claude Barats
Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program.
Breast cancer research and treatment 2004;88(2):117-29.
2004: Jean-Yves Pierga; Véronique Girre; Valérie Laurence; Bernard Asselain; Véronique Diéras; Michel Jouve; Philippe Beuzeboc; Alain Fourquet; Claude Nos; Brigitte Sigal-Zafrani; Pierre Pouillart
Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age.
Breast (Edinburgh, Scotland) 2004;13(5):369-75.
2004: Régis Peffault de Latour; Gaëtan des Guetz; Valérie Laurence; Thao Palangié; Jean-Yves Pierga; Véronique Diéras; Michel Jouve; Jean-Marc Extra; Pierre Pouillart; Didier Decaudin
Breast cancer associated with idiopathic thrombocytopenic purpura: a single center series of 10 cases.
American journal of clinical oncology 2004;27(4):333-6.
2004: Véronique Diéras; Véronique Girre; Jean-Yves Pierga; Valérie Laurence; Sophie Piperno-Neumann; Pierre Pouillart
[Update on docetaxel and breast cancer].
Bulletin du cancer 2004;91(5):409-17.
2004: Jean-Yves Pierga; Charlyne Bonneton; Anne Vincent-Salomon; Patricia de Cremoux; Claude Nos; Nathalie BLIN; Pierre Pouillart; Jean Paul Thiery; Henri Magdelénat
Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1392-400.
2004: Valérie Choesmel; Jean-Yves Pierga; Claude Nos; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Jean Paul Thiery; Nathalie BLIN
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
Breast cancer research : BCR 2004;6(5):R556-70.
2004: Jean-Yves Pierga; Laurent Deneux; Charlyne Bonneton; Anne Vincent-Salomon; Claude Nos; Philippe Anract; Henri Magdelénat; Pierre Pouillart; Jean Paul Thiery
Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients.
The International journal of biological markers 2004;19(1):23-31.
2003: Laurent Chauveinc; X Buthaud; Marie-Christine Falcou; Véronique Mosseri; Anne de La Rochefordière; Jean-Yves Pierga; Jacques Girodet; Rémy J Salmon
Anal canal cancer treatment: practical limitations of routine prescription of concurrent chemotherapy and radiotherapy.
British journal of cancer 2003;89(11):2057-61.
2003: Véronique Diéras; Jean-Yves Pierga; Anne Vincent-Salomon; Philippe Beuzeboc; Pierre Pouillart; Patricia de Cremoux
[Targeting epidermal growth factor receptor in cancer of the breast].
Bulletin du cancer 2003;90 Spec No():S257-62.
2003: Jean-Yves Pierga; Charlyne Bonneton; Henri Magdelénat; Anne Vincent-Salomon; Claude Nos; Pierre Pouillart; Jean Paul Thiery
Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer.
British journal of cancer 2003;89(3):539-45.
2003: Jean-Yves Pierga; E Mouret; Valérie Laurence; Véronique Diéras; A Savigioni; Philippe Beuzeboc; Thierry Dorval; Thao Palangié; Michel Jouve; Pierre Pouillart
Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer. the role of clinical response.
European journal of cancer (Oxford, England : 1990) 2003;39(8):1089-96.
2002: Gaëtan des Guetz; Ph de Mestier; Jean-Yves Pierga
[At last, an effective therapy for non-differentiated GI sarcomas (gastro intestinal stromal tumor)].
Journal de chirurgie 2002;139(5):268-73.
2001: Jean-Yves Pierga; Bernard Asselain; Michel Jouve; Véronique Diéras; Mathieu Carton; Valérie Laurence; Véronique Girre; Philippe Beuzeboc; Thao Palangié; Thierry Dorval; Pierre Pouillart
Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy.
Cancer 2001;91(6):1079-89.
2001: Jean-Yves Pierga; M Robain; Michel Jouve; Bernard Asselain; Véronique Diéras; Philippe Beuzeboc; Thao Palangié; Thierry Dorval; Jean-Marc Extra; Susy M Scholl; Pierre Pouillart
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):231-7.
2001: Véronique Diéras; Philippe Beuzeboc; Valérie Laurence; Jean-Yves Pierga; Pierre Pouillart
Interaction between Herceptin and taxanes.
Oncology 2001;61 Suppl 2():43-9.
2000: Theodore Girinsky; A Cordova; A Rey; Jean-Marc Cosset; Gérard Tertian; Jean-Yves Pierga
Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation.
International journal of radiation oncology, biology, physics 2000;48(5):1503-6.
2000: M Robain; Jean-Yves Pierga; Michel Jouve; Bernard Asselain; Véronique Diéras; Philippe Beuzeboc; Thao Palangié; Thierry Dorval; Jean-Marc Extra; Susy M Scholl; Pierre Pouillart
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(18):2301-12.
2000: Jean-Yves Pierga; E Mouret; Véronique Diéras; Valérie Laurence; Philippe Beuzeboc; Thierry Dorval; Thao Palangié; Michel Jouve; Anne Vincent-Salomon; Susy M Scholl; Jean-Marc Extra; Bernard Asselain; Pierre Pouillart
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer.
British journal of cancer 2000;83(11):1480-7.
2000: Alain Livartowski; Philippe Beuzeboc; B Le Vu; M Courbard; Jean-Yves Pierga; Jean-Marc Extra; Susy M Scholl; Pierre Pouillart
[How to finance chemotherapy with new cancer drugs?
Bulletin du cancer 2000;87(10):745-54.
2000: Patricia de Cremoux; Jean-Marc Extra; M G Denis; Jean-Yves Pierga; Edwige Bourstyn; Claude Nos; Krishna B Clough; Evelyne Boudou; Emmanuel MARTIN; A Müller; Pierre Pouillart; Henri Magdelénat
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3117-22.
1999: Sylvie Helfre; Jean-Yves Pierga
[Cerebral metastases: radiotherapy and chemotherapy].
Neuro-Chirurgie 1999;45(5):382-92.
1999: Jean-Yves Pierga; Khê Hoang-Xuan; Loïc Feuvret; Jean-Marc Simon; Philippe Cornu; François Baillet; J J Mazeron; J Y Delattre
Treatment of malignant gliomas in the elderly.
Journal of neuro-oncology 1999;43(2):187-93.
1999: A C Braud; Bernard Asselain; Susy M Scholl; Anne de La Rochefordière; T Palangie; Véronique Dieras; Jean-Yves Pierga; Thierry Dorval; Michel Jouve; Philippe Beuzeboc; Pierre Pouillart
Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse?
European journal of cancer (Oxford, England : 1990) 1999;35(3):392-7.
1999: Thao Palangié; Jean-Yves Pierga; Pierre Pouillart
Dose-intense salvage therapy after neoadjuvant chemotherapy: feasibility and preliminary results.
Cancer chemotherapy and pharmacology 1999;44 Suppl():S24-5.
1998: Rémy J Salmon; Bernard Asselain; Laurent Chauveinc; Bernard Dutrillaux; Marie-Christine Falcou; Jacques Girodet; Richard Hamelin; Pierre Laurent-Puig; Martine Muleris; Sylviane Olschwang; Jean-Yves Pierga; Yurgos Remvikos; Anne de La Rochefordière; Gilles Thomas
[Contributions of genetics in gastroenterology. Has genetic progress changed the therapeutic management of colorectal neoplasms? "Colon" Group of the Curie Institute].
Chirurgie; mémoires de l'Académie de chirurgie 1998;123(3):304-8.
1998: Jean-Yves Pierga; Michel Jouve; Bernard Asselain; Alain Livartowski; Philippe Beuzeboc; Véronique Diéras; Susy M Scholl; Thierry Dorval; Thao Palangié; E Garcia-Giralt; Pierre Pouillart
Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90).
British journal of cancer 1998;77(9):1474-9.
1998: Susy M Scholl; Philippe Beuzeboc; A L Harris; Jean-Yves Pierga; Bernard Asselain; Thao Palangié; Thierry Dorval; Michel Jouve; Véronique Diéras; Pierre Pouillart
Is primary chemotherapy useful for all patients with primary invasive breast cancer?
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():217-26.
1997: Jean-Yves Pierga; Véronique Diéras; Philippe Beuzeboc; Thierry Dorval; Thao Palangié; Michel Jouve; Susy M Scholl; E Garcia-Giralt; Pierre Pouillart
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
Gynecologic oncology 1997;66(2):246-9.
1997: R de Crevoisier; Jean-Yves Pierga; Rémi Dendale; Loïc Feuvret; Georges Noël; Jean-Marc Simon; Jean-Jacques Mazeron
[Radiotherapy of glioblastoma].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 1997;1(3):194-207.
1997: Jean-Yves Pierga; C Lainé-Bidron; Philippe Beuzeboc; Patricia de Crémoux; Pierre Pouillart; Henri Magdelénat
Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
British journal of cancer 1997;76(4):537-40.
1997: François Baillet; D Manoux; J Lange; J P Homasson; Jean-Marc Simon; C Diana; B Dessard-Diana; P Ronchin; Jean-Yves Pierga; Martin Housset; Jean-Jacques Mazeron; C Rozec
[Postoperative radiotherapy in non-small cell lung cancer. Apropos of a series of 374 cases].
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 1997;1(2):137-42.
1996: Véronique Dieras; Jean-Marc Extra; E Bellissant; Marc Espie; F Morvan; Jean-Yves Pierga; L Mignot; P Tresca; Michel Marty
Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(12):3097-104.
1996: Philippe Beuzeboc; Jean-Yves Pierga; D S Lyonnet; J Couturier; Pierre Pouillart
[Severe 5-fluorouracil toxicity in a woman treated for breast cancer with concurrent osteogenesis imperfecta and dehydrogenase deficiency].
Bulletin du cancer 1996;83(4):324-7.
1996: Philippe Beuzeboc; Jean-Yves Pierga; D Stoppa-Lyonnet; M C Etienne; G Milano; P Pouillart
Severe 5-fluorouracil toxicity possibly secondary to dihydropyrimidine dehydrogenase deficiency in a breast cancer patient with osteogenesis imperfecta.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):369-70.
1996: Jean-Yves Pierga; A Leroyer; P Viehl; Véronique Mosseri; Sylvie Chevillard; Henri Magdelénat
Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer.
Breast cancer research and treatment 1996;37(1):57-64.
1996: S Cammilleri; B Perdereau; F Brixy; Jean-Yves Pierga; B Benyahia; C Chypre; Henri Magdelenat
Imaging and biodistribution of 125I tyramine oligonucleotide in nude mice bearing human breast tumor. Preliminary report.
Bulletin du cancer 1996;83(1):23-26.
1996: Jean-Yves Pierga; Véronique Dieras; D Paraiso; Thierry Dorval; T Palangie; Philippe Beuzeboc; Michel Jouve; Susy M Scholl; E Garcia-Giralt; Pierre Pouillart
Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study.
Gynecologic oncology 1996;60(1):59-63.
1995: Jean-Yves Pierga; Véronique Dieras; D Paraiso; Pierre Pouillart
[Chemotherapy of metastatic endometrial carcinoma. Review of the literature].
Bulletin du cancer 1995;82(12):1005-18.
1995: Susy M Scholl; Jean-Yves Pierga; Bernard Asselain; Philippe Beuzeboc; Thierry Dorval; E Garcia-Giralt; Michel Jouve; Thao Palangié; Yurgos Remvikos; Jean-Claude Durand
Breast tumour response to primary chemotherapy predicts local and distant control as well as survival.
European journal of cancer (Oxford, England : 1990) 1995;31A(12):1969-75.
1995: Jean-Yves Pierga; Michel Jouve; B Asselain; Philippe Beuzeboc; Thierry Dorval; T Palangie; Véronique Dieras; E Garcia-Giralt; Susy M Scholl; Pierre Pouillart
Randomized trial comparing two different modalities of administration of the same cytotoxic drugs in metastatic breast cancer.
The Journal of infusional chemotherapy 1995;5(4):197-200.
1994: Jean-Yves Pierga; S Giacchetti; E Vilain; Jean-Marc Extra; P Brice; Marc Espie; J A Maragi; M Fellous; Michel Marty
Dysgerminoma in a pure 45,X Turner syndrome: report of a case and review of the literature.
Gynecologic oncology 1994;55(3 Pt 1):459-64.
1994: Jean-Yves Pierga; S Cammilleri; B Benyahia; Henri Magdelénat
[Applications of antisense oligonucleotides in oncology].
Bulletin du cancer 1994;81(12):1023-42.
1994: Jean-Yves Pierga; Henri Magdelenat
Applications of antisense oligonucleotides in oncology.
Cellular and molecular biology (Noisy-le-Grand, France) 1994;40(3):237-61.
1994: Jean-Yves Pierga; G Socie; Eliane Gluckman; Agnès Devergie; Michel Henry-Amar; André Bridier; Theodore Girinsky; J Nguyen; Jean-Marc Cosset
Secondary solid malignant tumors occurring after bone marrow transplantation for severe aplastic anemia given thoraco-abdominal irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(1):55-8.
1994: Susy M Scholl; Alain Fourquet; Bernard Asselain; Jean-Yves Pierga; J R Vilcoq; Jean-Claude Durand; Thierry Dorval; Thao Palangié; Michel Jouve; Philippe Beuzeboc
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6.
European journal of cancer (Oxford, England : 1990) 1994;30A(5):645-52.
1993: Jean-Yves Pierga; C Maunoury; H Valette; G Socie; Théo Girinski; G Tchernia; Michel Henry-Amar; A Desgrez; Jean-Marc Cosset
Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease.
International journal of radiation oncology, biology, physics 1993;25(5):871-6.
1993: Jean-Yves Pierga; Chantal Kalifa; Marie-José Terrier-Lacombe; Jean-Louis Habrand; Jean Lemerle
Carcinoma of the choroid plexus: a pediatric experience.
Medical and pediatric oncology 1993;21(7):480-7.
1992: Jean-Yves Pierga; P Beuzeboc; T Dorval; T Palangie; P Pouillart
Favourable outcome after plasmapheresis for vincristine overdose.
Lancet 1992;340(8812):185.
1992: C Maunoury; Jean-Yves Pierga; H Valette; G Tchernia; J M Cosset; A Desgrez
Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study.
European journal of nuclear medicine 1992;19(10):871-3.
1991: Jean-Yves Pierga; J Y Follezou; M Chelfi; Theodore Girinsky; G Socie; M Hayat; Jean-Marc Cosset
[Immediate hematologic tolerance of extended irradiations after chemotherapy. Apropos of 78 cases of Hodgkin's disease stage III and IV without marrow involvement treated at the Gustave-Roussy Institute].
Bulletin du cancer 1991;78(10):921-9.
1990: G Socie; Agnès Devergie; Jean-Marc Cosset; Jean-Yves Pierga; Hélène Esperou; Théo Girinski; Eliane Gluckman
Low-dose (one gray) total-lymphoid irradiation for extensive, drug-resistant chronic graft-versus-host disease.
Transplantation 1990;49(3):657-8.